Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lindemuth

Showing results (51-60 of 56) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 56 results.
Cell Host & Microbe|May 21, 2021
Modulating HIV-1 envelope glycoprotein conformation to decrease the HIV-1 reservoirJyothi K Rajashekar, Jonathan Richard, Jagadish Beloor, et al.
Nature Medicine|April 15, 2020
CTLA-4 and PD-1 dual blockade induces SIV reactivation without control of rebound after antiretroviral therapy interruptionJustin Harper, Shari Gordon, Chi Ngai Chan, et al.
Emerging Infectious Diseases|July 1, 2021
Predictors of Nonseroconversion after SARS-CoV-2 InfectionWeimin Liu, Ronnie M Russell, Frederic Bibollet-Ruche, et al.
The Journal of Clinical Investigation|November 17, 2021
A randomized controlled study of convalescent plasma for individuals hospitalized with COVID-19 pneumoniaKatharine J Bar, Pamela A Shaw, Grace H Choi, et al.
Mbio|January 11, 2023
A Germline-Targeting Chimpanzee SIV Envelope Glycoprotein Elicits a New Class of V2-Apex Directed Cross-Neutralizing AntibodiesFrederic Bibollet-Ruche, Ronnie M Russell, Wenge Ding, et al.
Science (New York, N.Y.)|November 20, 2020
Recapitulation of HIV-1 Env-antibody coevolution in macaques leading to neutralization breadthRyan S Roark, Hui Li, Wilton B Williams, et al.
Pageof 6

Showing results (51-60 of 56) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 56 results.
Cell Host & Microbe|May 21, 2021
Modulating HIV-1 envelope glycoprotein conformation to decrease the HIV-1 reservoirJyothi K Rajashekar, Jonathan Richard, Jagadish Beloor, et al.
Nature Medicine|April 15, 2020
CTLA-4 and PD-1 dual blockade induces SIV reactivation without control of rebound after antiretroviral therapy interruptionJustin Harper, Shari Gordon, Chi Ngai Chan, et al.
Emerging Infectious Diseases|July 1, 2021
Predictors of Nonseroconversion after SARS-CoV-2 InfectionWeimin Liu, Ronnie M Russell, Frederic Bibollet-Ruche, et al.
The Journal of Clinical Investigation|November 17, 2021
A randomized controlled study of convalescent plasma for individuals hospitalized with COVID-19 pneumoniaKatharine J Bar, Pamela A Shaw, Grace H Choi, et al.
Mbio|January 11, 2023
A Germline-Targeting Chimpanzee SIV Envelope Glycoprotein Elicits a New Class of V2-Apex Directed Cross-Neutralizing AntibodiesFrederic Bibollet-Ruche, Ronnie M Russell, Wenge Ding, et al.
Science (New York, N.Y.)|November 20, 2020
Recapitulation of HIV-1 Env-antibody coevolution in macaques leading to neutralization breadthRyan S Roark, Hui Li, Wilton B Williams, et al.
Pageof 6